Prophylactic Donor Lymphocyte Infusion to Prevent Relapse after Allogeneic Stem Cell Transplantation
Journal Title: Journal of Clinical & Medical Case Reports - Year 2014, Vol 1, Issue 1
Abstract
Donor lymphocyte infusion (DLI) has been used to treat disease relapse after stem cell transplantation, but high incidence of graftversus- host disease (GVHD) after traditional DLI, and low response rates with robust relapse in acute leukemia have limited its wide application. Nonetheless, the promising graft versus leukemia effect elicited by DLI makes it a viable option, especially in the state of minimal residual disease after stem cell transplantation. Prophylactic donor lymphocyte infusion has been explored as a more tolerable, less toxic and efficacious option to prevent relapse. This review will summarize the results of the latest prophylactic DLI studies, and discuss our ongoing prophylactic DLI clinical trial after T cell depleted stem cell transplantation in patients with high risk hematologic malignancies.
Authors and Affiliations
Hongtao Liu
Keywords
Related Articles
- EP ID EP207581
- DOI 10.13188/2332-4120.1000002
- Views 167
- Downloads 0
Congestive Heart Failure Treated with a Multiple Micronutrient Supplement Program: A Case Report
Congestive heart failure is a chronic progressive disorder of the cardiovascular system with loss of function of the cardiac myocytes. There is no cure and treatments only attempt to reduce the severity of symptoms. We p...
Alcohol Abuse, Reproductive Coercion and Intimate Partner Violence: Case Reports and Mini-Review
This article presents a continuation of report series on alcohol abuse, reproductive coercion and intimate partner violence. The abortion rate in the former Soviet Union has been the highest in the world, caused not only...
Auto-Brewery as an Emerging Syndrome: Three Representative Case Studies
Auto-Brewery or Gut Fermentation Syndrome, also known as intestinal candidiasis, is a very rare phenomenon heretofore unstudied and underreported. Since the most recent case study of a man in Texas with the syndrome was...
Giant Intraductal Papilloma: A Rare Case
Intraductal papilloma is a benign fibroepithelial tumor of the breast. It constitutes approximately 5% of all breast cancers. Although it can be seen at any age, it is mostly seen in late reproductive age and during peri...
The Use of Multiplex Ligation- Dependent Probe Amplification Technology for Genetic Analysis of the Entire PKD1 Gene and PKD2 Gene
Genetic screening of the PKD1 and PKD2 genes using the MLPA method may decrease cost and labor. Indeed, the MLPA method was especially useful in cases exhibiting juvenile onset and rapid kidney enlargement. Case 1 had gr...